On December 4, 2024, the Food and Drug Administration sanctioned durvalumab (Imfinzi, AstraZeneca) for adults with limited-stage small cell lung cancer (LS-SCLC) whose condition remains stable after...
lung-cancer-treatment-options
Lung Cancer Targeted Therapy
Lung cancer targeted therapy has revolutionized the treatment of advanced-stage lung cancer, providing a more tailored and efficient treatment than conventional chemother...
lung-cancer-treatment-options